INSIGHTS ON PHARMACEUTICAL PACKAGING

PHARMACEUTICAL PACKAGING SOLUTIONS

  • We have over 50 years’ experience in the pharmaceutical contract packaging sector with significant capabilities and expertise in the commercial packaging of biologics and biosimilars.

  • Our experience in commercial product launch is unparalleled. PCI affords its customers agility in a dynamic commercial market, with the flexibility to adapt quickly to changing market demands.

  • Backed by our technology and team of experts, Mikart is equipped to help you develop and manufacture palatable pediatric dosage forms from preclinical to commercial launch.

  • The growing need for convenient and tamper-free packaging has proliferated the demand for blister packaging. Learn about contract blister packaging services that can produce several different packaging forms.

  • The VeriPac 465 performs leak detection based on the basic principles of physics and does not require the use of trace gasses or sample preparation to perform the test. The VeriPac 465 core technology is based on the ASTM vacuum decay leak test method (F2338) recognized by the FDA as a consensus standard for package integrity testing. This test method was developed using VeriPac leak test instruments.